David Sancho

28PUBLICATIONS
193CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Dec 12, 2025
A circadian checkpoint relocates neutrophils to minimize injury.

Alejandra Aroca-Crevillén, Sandra Martín-Salamanca, Lidiane S Torres

|Nov 25, 2025
pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection.

Elena Hernández-García, Miguel Galán, Sofía C Khouili

|Jul 16, 2025
Imidazole propionate is a driver and therapeutic target in atherosclerosis.

Annalaura Mastrangelo, Iñaki Robles-Vera, Diego Mañanes

|May 30, 2025
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.

Miguel Galán, Laura Fernández-Méndez, Vanessa Núñez

Pageof 5